Search by Drug Name or NDC
NDC 10599-0003-01 Sinuva 1350 ug/1 Details
Sinuva 1350 ug/1
Sinuva is a INTRASINAL IMPLANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Intersect ENT, Inc.. The primary component is MOMETASONE FUROATE.
Product Information
NDC | 10599-0003 |
---|---|
Product ID | 10599-003_508796b2-418c-402f-a33f-5766a8d4c18b |
Associated GPIs | 42200045102350 |
GCN Sequence Number | 078014 |
GCN Sequence Number Description | mometasone furoate IMPLANT 1350 MCG NASAL |
HIC3 | Q7P |
HIC3 Description | NASAL ANTI-INFLAMMATORY STEROIDS |
GCN | 44214 |
HICL Sequence Number | 003329 |
HICL Sequence Number Description | MOMETASONE FUROATE |
Brand/Generic | Brand |
Proprietary Name | Sinuva |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | mometasone furoate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | IMPLANT |
Route | INTRASINAL |
Active Ingredient Strength | 1350 |
Active Ingredient Units | ug/1 |
Substance Name | MOMETASONE FUROATE |
Labeler Name | Intersect ENT, Inc. |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA209310 |
Listing Certified Through | 2024-12-31 |
Package
NDC 10599-0003-01 (10599000301)
NDC Package Code | 10599-003-01 |
---|---|
Billing NDC | 10599000301 |
Package | 1 POUCH in 1 CARTON (10599-003-01) / 1 IMPLANT in 1 POUCH |
Marketing Start Date | 2018-02-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |